+91 789 2456 581 | info@nckpharma.com

Pharma News

Keep updating your pharma knowledge
24 Jun 2019

What is CRL – Complete Response Letter by USFDA?

/
Posted By
/
Comments0
/

Complete response letter is issued by USFDA to new drug / abbreviated application holder, if they determines that we will not approve the application or abbreviated application in its present form for one or more of the reasons.

CRL contains

  • Description of specific deficiencies.
  • Complete review of data.
  • In case of Inadequate data, they highlights inadequacy.
  • They also mention recommended action for approval.

Leave a Reply

Scale up your Pharma knwledge to Next Level with our Free Content

Case studies & Caselets
Simulation based learning
Online self competency assessment tests 

etc.